Effect of new polyherbal formulations DF1911, DF2112 and DF2813 on CFA induced inflammation in rat model

Abstract Background Aim of the present study was to evaluate anti-inflammatory activity of newly developed polyherbal formulations DF1911, DF2112 and DF2813. These newly developed formulations are modifications of Dashamoola, a well known Ayurvedic formulation, along with addition of new plants. Met...

Full description

Bibliographic Details
Main Authors: Bhagyashri Nagarkar, Suresh Jagtap
Format: Article
Language:English
Published: BMC 2017-04-01
Series:BMC Complementary and Alternative Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12906-017-1711-6
_version_ 1818049338022035456
author Bhagyashri Nagarkar
Suresh Jagtap
author_facet Bhagyashri Nagarkar
Suresh Jagtap
author_sort Bhagyashri Nagarkar
collection DOAJ
description Abstract Background Aim of the present study was to evaluate anti-inflammatory activity of newly developed polyherbal formulations DF1911, DF2112 and DF2813. These newly developed formulations are modifications of Dashamoola, a well known Ayurvedic formulation, along with addition of new plants. Methods Complete Freund’s adjuvant (CFA) induced inflammation in rat was used as an experimental model. Effects of the treatment in rats were monitored by physiological and biochemical parameters, histopathology and through gene expression studies. Results Diclofenac sodium showed maximum percentage inhibition (56.8 ± 3.5%) of paw edema followed by Dashamoola Kwatha (19.9 ± 1.8%). Among test formulations treated groups, DF1911 at 250 mg/kg bw (48.2 ± 5.4%, p < 0.001) and DF2112 at 250 mg/kg bw (49.9 ± 3.5%, p < 0.001) showed significant and maximum increase in percentage inhibition of paw edema as compared to Dashamoola Kwatha. Hematological alterations in CFA rats were normalized after treatment with test formulations. Results of serum markers and histopathological observations also supported the activity of formulations. Increased MDA levels in liver tissue of CFA injected animals significantly (p < 0.05) decreased by Diclofenac sodium and test formulation treated groups. DF1911, DF2112 and DF2813 showed down-regulation of IL1-β (~6.4-fold, ~5.2-fold and ~7.6-fold), IL-6 (~1.1-fold, ~1.6-fold and ~1.9-fold), TNF-α (~2.0-fold, ~4.6-fold and ~3.5-fold), and iNOS (~1.2-fold, ~1.8-fold and ~1.1-fold) in inflamed paw tissue compared to negative control group, respectively. Conclusions The anti-inflammatory effects of DF1911 and DF2112 in rats were significantly higher than the Dashamoola Kwatha and are comparable to Diclofenac sodium.
first_indexed 2024-12-10T10:35:59Z
format Article
id doaj.art-68d8c81717a04cd8985b02bd1dbc0429
institution Directory Open Access Journal
issn 1472-6882
language English
last_indexed 2024-12-10T10:35:59Z
publishDate 2017-04-01
publisher BMC
record_format Article
series BMC Complementary and Alternative Medicine
spelling doaj.art-68d8c81717a04cd8985b02bd1dbc04292022-12-22T01:52:26ZengBMCBMC Complementary and Alternative Medicine1472-68822017-04-0117111210.1186/s12906-017-1711-6Effect of new polyherbal formulations DF1911, DF2112 and DF2813 on CFA induced inflammation in rat modelBhagyashri Nagarkar0Suresh Jagtap1Department of Herbal Medicine, Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth Deemed UniversityDepartment of Herbal Medicine, Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth Deemed UniversityAbstract Background Aim of the present study was to evaluate anti-inflammatory activity of newly developed polyherbal formulations DF1911, DF2112 and DF2813. These newly developed formulations are modifications of Dashamoola, a well known Ayurvedic formulation, along with addition of new plants. Methods Complete Freund’s adjuvant (CFA) induced inflammation in rat was used as an experimental model. Effects of the treatment in rats were monitored by physiological and biochemical parameters, histopathology and through gene expression studies. Results Diclofenac sodium showed maximum percentage inhibition (56.8 ± 3.5%) of paw edema followed by Dashamoola Kwatha (19.9 ± 1.8%). Among test formulations treated groups, DF1911 at 250 mg/kg bw (48.2 ± 5.4%, p < 0.001) and DF2112 at 250 mg/kg bw (49.9 ± 3.5%, p < 0.001) showed significant and maximum increase in percentage inhibition of paw edema as compared to Dashamoola Kwatha. Hematological alterations in CFA rats were normalized after treatment with test formulations. Results of serum markers and histopathological observations also supported the activity of formulations. Increased MDA levels in liver tissue of CFA injected animals significantly (p < 0.05) decreased by Diclofenac sodium and test formulation treated groups. DF1911, DF2112 and DF2813 showed down-regulation of IL1-β (~6.4-fold, ~5.2-fold and ~7.6-fold), IL-6 (~1.1-fold, ~1.6-fold and ~1.9-fold), TNF-α (~2.0-fold, ~4.6-fold and ~3.5-fold), and iNOS (~1.2-fold, ~1.8-fold and ~1.1-fold) in inflamed paw tissue compared to negative control group, respectively. Conclusions The anti-inflammatory effects of DF1911 and DF2112 in rats were significantly higher than the Dashamoola Kwatha and are comparable to Diclofenac sodium.http://link.springer.com/article/10.1186/s12906-017-1711-6Anti-inflammatoryNew poly-herbal formulationsDashamoola KwathaComplete Freund’s Adjuvant
spellingShingle Bhagyashri Nagarkar
Suresh Jagtap
Effect of new polyherbal formulations DF1911, DF2112 and DF2813 on CFA induced inflammation in rat model
BMC Complementary and Alternative Medicine
Anti-inflammatory
New poly-herbal formulations
Dashamoola Kwatha
Complete Freund’s Adjuvant
title Effect of new polyherbal formulations DF1911, DF2112 and DF2813 on CFA induced inflammation in rat model
title_full Effect of new polyherbal formulations DF1911, DF2112 and DF2813 on CFA induced inflammation in rat model
title_fullStr Effect of new polyherbal formulations DF1911, DF2112 and DF2813 on CFA induced inflammation in rat model
title_full_unstemmed Effect of new polyherbal formulations DF1911, DF2112 and DF2813 on CFA induced inflammation in rat model
title_short Effect of new polyherbal formulations DF1911, DF2112 and DF2813 on CFA induced inflammation in rat model
title_sort effect of new polyherbal formulations df1911 df2112 and df2813 on cfa induced inflammation in rat model
topic Anti-inflammatory
New poly-herbal formulations
Dashamoola Kwatha
Complete Freund’s Adjuvant
url http://link.springer.com/article/10.1186/s12906-017-1711-6
work_keys_str_mv AT bhagyashrinagarkar effectofnewpolyherbalformulationsdf1911df2112anddf2813oncfainducedinflammationinratmodel
AT sureshjagtap effectofnewpolyherbalformulationsdf1911df2112anddf2813oncfainducedinflammationinratmodel